Diseases [C] » Digestive System Diseases [C06] » Gastrointestinal Diseases » Gastroenteritis
Description
INFLAMMATION of any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM. Causes of gastroenteritis are many including genetic, infection, HYPERSENSITIVITY, drug effects, and CANCER. MeSH
Hierarchy View
Subtype Terms (12)
Appendicitis
58 drugs (50 approved, 8 experimental)
Colitis
29 drugs (20 approved, 9 experimental)
Diverticular Diseases
4 drugs (2 approved, 2 experimental)
Dysentery
14 drugs (7 approved, 7 experimental)
Enteritis
15 drugs (4 approved, 11 experimental)
Enterocolitis
9 drugs (6 approved, 3 experimental)
Esophagitis
33 drugs (15 approved, 18 experimental)
Gastritis
86 drugs (35 approved, 51 experimental)
Inflammatory Bowel Diseases
167 drugs (91 approved, 76 experimental)
Mucositis
111 drugs (63 approved, 48 experimental)
Proctitis
10 drugs (7 approved, 3 experimental)
Approved Indicated Drugs (1)
Phase 4 Indicated Drugs (15)
Phase 3 Indicated Drugs (16)
Phase 2 Indicated Drugs (4)
Phase 1 Indicated Drugs (5)
Other Experimental Indicated Drugs (3)
Organization Involved with Phase 4 Indications (30)
Ankara Yildirim Beyazıt University
Bill and Melinda Gates Foundation
Canadian Association of Emergency Physicians
Centers for Disease Control and Prevention (CDC)
Organization Involved with Phase 3 Indications (62)
Alberta Children's Hospital Research Institute
Arhangelsk Regional Children's Clinical Hospital named after Vizshletsov P.G.
Bharat Biotech International Limited
Canadian Institutes of Health Research (CIHR)
Centre for Infectious Disease Research in Zambia (CIDRZ)
Children's Hospital Research Institute of Manitoba
Children's National Medical Center
Hospital General Naval de Alta Especialidad
Liaoning Hospital of Traditional Chinese Medicine
Pirogov Russian National Research Medical University
Serum Institute of India Pvt. Ltd.
Shirdi Sai Baba Rural Hospital
St. Marianna University School of Medicine
Szpital im. Św. Jadwigi Śląskiej
The University of Texas, Dallas
Organization Involved with Phase 2 Indications (18)
Organization Involved with Phase 1 Indications (6)
Organization Involved with Other Experimental Indications (8)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
